Journal article
Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer
Oncotarget, Vol.8(16), pp.27199-27215
04/18/2017
DOI: 10.18632/oncotarget.16109
PMCID: PMC5432329
PMID: 28423712
Abstract
We demonstrate that model-based unsupervised learning can uniquely discriminate single-cell subpopulations by their gene expression distributions, which in turn allow us to identify specific genes for focused functional studies. This method was applied to MDA-MB-231 breast cancer cells treated with the antidiabetic drug metformin, which is being repurposed for treatment of triple-negative breast cancer. Unsupervised learning identified a cluster of metformin-treated cells characterized by a significant suppression of 230 genes (p-value < 2E-16). This analysis corroborates known studies of metformin action: a) pathway analysis indicated known mechanisms related to metformin action, including the citric acid (TCA) cycle, oxidative phosphorylation, and mitochondrial dysfunction (p-value < 1E-9); b) 70% of these 230 genes were functionally implicated in metformin response; c) among remaining lesser functionally-studied genes for metformin-response was CDC42, down-regulated in breast cancer treated with metformin. However, CDC42's mechanisms in metformin response remained unclear. Our functional studies showed that CDC42 was involved in metformin-induced inhibition of cell proliferation and cell migration mediated through an AMPK-independent mechanism. Our results points to 230 genes that might serve as metformin response signatures, which needs to be tested in patients treated with metformin and, further investigation of CDC42 and AMPK-independence's role in metformin's anticancer mechanisms.
Details
- Title: Subtitle
- Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer
- Creators
- Arjun P Athreya - University of Illinois Urbana-ChampaignKrishna R Kalari - Mayo Clinic in FloridaJunmei Cairns - Mayo ClinicAlan J Gaglio - University of Illinois Urbana-ChampaignQuin F Wills - MRC Weatherall Institute of Molecular MedicineNifang Niu - University of ChicagoRichard Weinshilboum - Mayo ClinicRavishankar K Iyer - University of Illinois Urbana-ChampaignLiewei Wang - Mayo Clinic
- Resource Type
- Journal article
- Publication Details
- Oncotarget, Vol.8(16), pp.27199-27215
- DOI
- 10.18632/oncotarget.16109
- PMID
- 28423712
- PMCID
- PMC5432329
- NLM abbreviation
- Oncotarget
- ISSN
- 1949-2553
- eISSN
- 1949-2553
- Publisher
- Impact Journals LLC
- Grant note
- U19 GM061388 / NIGMS NIH HHS P50 CA116201 / NCI NIH HHS R01 CA196648 / NCI NIH HHS R01 GM028157 / NIGMS NIH HHS
- Language
- English
- Date published
- 04/18/2017
- Academic Unit
- Stead Family Department of Pediatrics; Medical Genetics and Genomics
- Record Identifier
- 9984701545402771
Metrics
6 Record Views